241 related articles for article (PubMed ID: 23649946)
1. Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema.
Owen LA; Hartnett ME
Curr Diab Rep; 2013 Aug; 13(4):476-80. PubMed ID: 23649946
[TBL] [Abstract][Full Text] [Related]
2. Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography.
Bandyopadhyay S; Bandyopadhyay SK; Saha M; Sinha A
Int Ophthalmol; 2018 Feb; 38(1):241-249. PubMed ID: 28160192
[TBL] [Abstract][Full Text] [Related]
3. Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.
Hillier RJ; Ojaimi E; Wong DT; Mak MYK; Berger AR; Kohly RP; Kertes PJ; Forooghian F; Boyd SR; Eng K; Altomare F; Giavedoni LR; Nisenbaum R; Muni RH
JAMA Ophthalmol; 2018 Apr; 136(4):382-388. PubMed ID: 29522144
[TBL] [Abstract][Full Text] [Related]
4. Anti-VEGF Therapy Reduces Inflammation in Diabetic Macular Edema.
Imazeki M; Noma H; Yasuda K; Motohashi R; Goto H; Shimura M
Ophthalmic Res; 2021; 64(1):43-49. PubMed ID: 32454504
[TBL] [Abstract][Full Text] [Related]
5. Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
Umazume K; Usui Y; Wakabayashi Y; Okunuki Y; Kezuka T; Goto H
Retina; 2013 May; 33(5):1020-5. PubMed ID: 23095769
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranibizumab on growth factors and mediators of inflammation in the aqueous humor of patients with diabetic macular edema.
Utsumi T; Noma H; Yasuda K; Goto H; Shimura M
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2597-2603. PubMed ID: 33772356
[TBL] [Abstract][Full Text] [Related]
7. Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
Felfeli T; Juncal VR; Hillier RJ; Mak MYK; Wong DT; Berger AR; Kohly RP; Kertes PJ; Eng KT; Boyd SR; Altomare F; Giavedoni LR; Muni RH
Am J Ophthalmol; 2019 Oct; 206():176-183. PubMed ID: 30959004
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
Noma H; Yasuda K; Shimura M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810434
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
[TBL] [Abstract][Full Text] [Related]
10. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
11. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Kim Y; Lee SJ
Indian J Ophthalmol; 2015 Apr; 63(4):312-7. PubMed ID: 26044469
[TBL] [Abstract][Full Text] [Related]
12. New Insights in Resistant Diabetic Macular Edema.
Kuroiwa DAK; Malerbi FK; Regatieri CVS
Ophthalmologica; 2021; 244(6):485-494. PubMed ID: 34023834
[TBL] [Abstract][Full Text] [Related]
13. Aqueous Humor Levels of Soluble Vascular Endothelial Growth Factor Receptor and Inflammatory Factors in Diabetic Macular Edema.
Noma H; Mimura T; Yasuda K; Motohashi R; Kotake O; Shimura M
Ophthalmologica; 2017; 238(1-2):81-88. PubMed ID: 28564655
[TBL] [Abstract][Full Text] [Related]
14. Diabetic macular edema.
Lang GE
Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
[TBL] [Abstract][Full Text] [Related]
15. Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema.
Zhu D; Zhu H; Wang C; Yang D
Indian J Ophthalmol; 2014 Mar; 62(3):295-8. PubMed ID: 23619489
[TBL] [Abstract][Full Text] [Related]
16. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Boiko EV; Maltsev DS
Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
[TBL] [Abstract][Full Text] [Related]
18. Evidence for anti-VEGF treatment of diabetic macular edema.
Bandello F; Berchicci L; La Spina C; Battaglia Parodi M; Iacono P
Ophthalmic Res; 2012; 48 Suppl 1():16-20. PubMed ID: 22907145
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and Growth Factors as Predictors of Response to Medical Treatment in Diabetic Macular Edema.
Torres-Costa S; Alves Valente MC; Falcão-Reis F; Falcão M
J Pharmacol Exp Ther; 2020 Jun; 373(3):445-452. PubMed ID: 32245883
[TBL] [Abstract][Full Text] [Related]
20. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
